Optimizing Flumatinib Therapy in Chinese Chronic-Phase Chronic Myeloid Leukemia Based on Therapeutic Drug Monitoring
Fang Cheng,1,2,* Fan Wang,3,* Zheng Cui,2 Qiang Li,2 Xin Liu,1 Weiming Li4 1Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, Hubei, People’s Republic of China; 2Department of Pharmacy, Union Ho...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Dove Medical Press
2026-06-01
|
| Sraith: | Drug Design, Development and Therapy |
| Ábhair: | |
| Rochtain ar líne: | https://www.dovepress.com/optimizing-flumatinib-therapy-in-chinese-chronic-phase-chronic-myeloid-peer-reviewed-fulltext-article-DDDT |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
